Arkolith/Insider Trading/VERA/Form 4

Fordyce Marshall

PRESIDENT AND CEO, DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2026Sell(S)14K$43.66$617K244K
Apr 14, 2026Sell(S)8K$44.58$353K236K
Apr 14, 2026Sell(S)900$45.51$41K235K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859453-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML